Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU
Open Access
- 15 February 2019
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 14 (1) , 1-12
Abstract
In phenylketonuria, casein glycomacropeptide (CGMP) requires modification with the addition of some essential and semi essential amino acids to ensure suitability as a protein substitute. The optimal amount and ratio of additional amino acids is undefined. A longitudinal, parallel, controlled study over 12 months evaluating a CGMP (CGMP-AA2) formulation compared with phenylalanine-free L-amino acid supplements (L-AA) on blood Phe, Tyr, Phe:Tyr ratio, biochemical nutritional status and growth in children with PKU. The CGMP-AA2 contained 36 mg Phe per 20 g protein equivalent. Children with PKU, with a median age of 9.2 y (5-16y) were divided into 2 groups: 29 were given CGMP-AA2, 19 remained on Phe-free L-AA. The CGMP-AA2 formula gradually replaced L-AA, providing blood Phe concentrations were maintained within target range. Median blood Phe, Tyr, Phe:Tyr ratio and anthropometry, were compared within and between the two groups at baseline, 26 and 52 weeks. Nutritional biochemistry was studied at baseline and 26 weeks only. At the end of 52 weeks only 48% of subjects were able to completely use CGMP-AA2 as their single source of protein substitute. At 52 weeks CGMP-AA2 provided a median of 75% (30–100) of the total protein substitute with the remainder being given as L-AA. Within the CGMP-AA2 group, blood Phe increased significantly between baseline and 52 weeks: [baseline to 26 weeks; baseline Phe 270 μmol/L (170–430); 26 weeks, Phe 300 μmol/L (125–485) p = 0.06; baseline to 52 weeks: baseline, Phe 270 μmol/L (170–430), 52 weeks Phe 300 μmol/L (200–490), p < 0.001)]. However, there were no differences between the CGMP-AA2 and L-AA group for Phe, Tyr, Phe:Tyr ratio or anthropometry at any of the three measured time points. Within the CGMP-AA2 group only weight (p = 0.0001) and BMI z scores (p = 0.0001) increased significantly between baseline to 52 weeks. Whole blood and plasma selenium were significantly higher (whole blood selenium [p = 0.0002]; plasma selenium [p = 0.0007]) at 26 weeks in the CGMP-AA2 group compared L-AA. No differences were observed within the L-AA group for any of the nutritional markers. CGMP-AA increases blood Phe concentrations and so it can only be used partly to contribute to protein substitute in some children with PKU. CGMP-AA should be carefully introduced in children with PKU and close monitoring of blood Phe control is essential.Keywords
Funding Information
- Vitaflo
This publication has 39 references indexed in Scilit:
- Low Bone Strength Is a Manifestation of Phenylketonuria in Mice and Is Attenuated by a Glycomacropeptide DietPLOS ONE, 2012
- Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuriaAmerican Journal of Physiology-Endocrinology and Metabolism, 2012
- Large neutral amino acids in the treatment of PKU: from theory to practiceJournal of Inherited Metabolic Disease, 2010
- Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acidsThe American Journal of Clinical Nutrition, 2009
- Effects of Various Dietary Amino Acid Preparations for Phenylketonuric Patients on the Metabolic Profiles along with Postprandial Insulin and Ghrelin ResponsesAnnals of Nutrition and Metabolism, 2007
- Large neutral amino acids in the treatment of phenylketonuria (PKU)Journal of Inherited Metabolic Disease, 2006
- Selenium Content and Distribution in Cow's Milk Supplemented with Two Dietary Selenium SourcesJournal of Agricultural and Food Chemistry, 2005
- Complex Taste--Taste of D-amino AcidsChemical Senses, 2005
- Effect of Simultaneous Ingestion of L‐Amino Acids and Whole Protein on Plasma Amino Acid and Urea Nitrogen Concentrations in HumansJournal of Parenteral and Enteral Nutrition, 1991
- The stimulus‐secretion coupling of amino acid‐induced insulin release: insulinotropic action of branched‐chain amino acids at physiological concentrations of glucose and glutamineEuropean Journal of Clinical Investigation, 1981